The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 12.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 49%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (9 analysts) rates it buy, with a mean price target of $22.
Alkami Technology, Inc.
ALKT · Nasdaq · USD · Market cap $2.0B · 1,225 employees
Alkami Technology, Inc.
FAIL · Does not pass the screenAt the last full screen
2026-09-16
Screened 2026-09-16 · the tape above runs as of 19:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its distribution label.
Alkami Technology, Inc. holds its Distribution at $18.94. The statistical read favours the sellers, held for 87 days.
| Phase | Distribution · caution |
| Quantitative state | The statistical read favours the sellers, held for 87 days |
| Price at the screen | $18.94 |
| Valuation | N/A trailing · 17.43 forward price to earnings |
| Values screen | FAIL · score 70.0 |
| Beta | 0.61 |
Five Screens, Shown in Full
Does not pass. Debt ratio
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 43.50% | Below 33% | Interest-bearing debt is 43.5% of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | 4.21% | Below 33% | Cash held in interest-bearing accounts and securities is 4.2% of assets, under the one-third limit. | Pass |
| Receivables | 12.70% | Below 49% | Money owed to the company is 12.7% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.94% | Below 5% | Only 0.9% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-09-16 screen. The gold marker is the market price at the same screen. A 10.3% margin of safety to the base estimate.
Third-party analyst targets: 7 covering, consensus Buy. The average target sits +11% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-16 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsDigital Banking Tools That Still Lose Money
Picture a US bank trying to keep customers from switching to an app that actually works. Alkami builds the cloud platform that handles onboarding and daily banking for smaller financial institutions. Revenue is growing at 29 percent a year, yet the business still posts an 11 percent negative profit margin and a negative 14 percent return on equity, so the numbers have not yet turned into cash.
We pass because the opportunity rating is none despite the 41 percent gap between the current price and our fair value. Forward earnings sit at 15.8 times, the moat is unknown, and seven analysts offer no consensus. Growth alone does not clear the bar when profits remain absent and the competitive edge is unproven.
Risk sits in the continued losses and the question of whether smaller banks will keep paying up once bigger platforms copy the features. The ethical screen passes cleanly, but that does not remove the execution gap. Analysis, not advice.
| Forward P/E | 17.4xfairly priced for its growth rate |
| EPS, trailing | -0.43 |
| EPS, forward | 1.09 |
| Revenue growth | +15.9%steady growth |
| Profit margin | -9.2%currently unprofitable |
| Return on equity | -12.8%not currently earning a positive return on equity |
| FCF yield | 4.10% |
| Debt to equity | 0.99moderate, manageable leverage |
| Current ratio | 2.13comfortably covers its short-term bills |
| Beta | 0.61steadier than the market |
| Short interest, float | 0.09% |
| 52-week range | 13.98 - 26.89 |
| Market cap | $2.0B |
| Employees | 1,225 |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeALKT trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 17.9% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 49%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (9 analysts) rates it buy, with a mean price target of $22.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 49%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (9 analysts) rates it buy, with a mean price target of $22.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 49%. Our forward projection puts the odds of a 10% gain over the next month near 20%. The street (9 analysts) rates it buy, with a mean price target of $22.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows negative risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $17.22 | -11.6% | · | $884 | -11.6% |
| 2 months | $16.13 | -5.6% | · | $944 | -5.6% |
| 3 months | $18.07 | -15.7% | · | $843 | -15.7% |
| 6 months | $22.49 | -32.3% | · | $677 | -32.3% |
| 1 year | $29.72 | -48.8% | · | $512 | -48.8% |
| 2 years | $27.12 | -43.8% | · | $562 | -43.8% |
| 3 years | $15.35 | -0.8% | · | $992 | -0.8% |
| 5 years | $32.01 | -52.4% | · | $476 | -52.4% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever ALKT does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.